PharVision Advisers’s InMode INMD Stock Holding History

PharVision Advisers’s Portfolio INMD Stock Details INMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-32,019	Closed	-$535K	–	392
2024 Q4	$535K	Buy	+32,019	New	+$568K	0.45%	34

Other funds holding INMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

PharVision Advisers's INMD Position: Q1 2025 in Review

PharVision Advisers sold out of InMode (INMD) in Q1 2025, closing a stake of 32,019 shares — an estimated $535K sold.

PharVision Advisers first reported a position in INMD in Q4 2024 and held it in 1 quarter. The position peaked at $535K in Q4 2024. 246 funds tracked by Wall St. Rank hold INMD as of Q1 2025.

PharVision Advisers reported no remaining InMode position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 32,019 InMode shares in Q1 2025, an estimated $535K.
PharVision Advisers first reported a position in InMode in Q4 2024 and held it in 1 quarter.
PharVision Advisers's InMode position peaked at $535K in Q4 2024.
246 funds tracked by Wall St. Rank held InMode as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.